By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – OncoVista Innovative Therapies announced that it has sold its majority stake in tumor diagnostics subsidiary AdnaGen to an entity called Alere Holdings Bermuda Limited Canon's Court.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: variant linked to obesity risk in Samoans, health of cloned animals, and more.
In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.
At Nature, John Wilbanks and Eric Topol call for openness in health data.
Law.com predicts that genomic and genetic testing will become common in toxic tort cases.